000 01377 a2200409 4500
005 20250517032113.0
264 0 _c20161213
008 201612s 0 0 eng d
022 _a1346-8138
024 7 _a10.1111/1346-8138.12903
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aUmezawa, Yoshinori
245 0 0 _aUstekinumab treatment in patients with psoriasis undergoing hemodialysis.
_h[electronic resource]
260 _bThe Journal of dermatology
_cJul 2015
300 _a731-4 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aDermatologic Agents
_xadverse effects
650 0 4 _aHumans
650 0 4 _aKidney Failure, Chronic
_xcomplications
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPsoriasis
_xcomplications
650 0 4 _aRenal Dialysis
650 0 4 _aSeverity of Illness Index
650 0 4 _aUstekinumab
_xadverse effects
700 1 _aHayashi, Mitsuha
700 1 _aKikuchi, Sota
700 1 _aFukuchi, Osamu
700 1 _aYanaba, Koichi
700 1 _aIto, Toshihiro
700 1 _aAsahina, Akihiko
700 1 _aSaeki, Hidehisa
700 1 _aNakagawa, Hidemi
773 0 _tThe Journal of dermatology
_gvol. 42
_gno. 7
_gp. 731-4
856 4 0 _uhttps://doi.org/10.1111/1346-8138.12903
_zAvailable from publisher's website
999 _c24886496
_d24886496